标题
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
作者
关键词
Subjective cognitive decline, Mild cognitive impairment, Dementia, Alzheimer’s disease, Positron emission tomography, Cerebrospinal fluid, Amyloid
出版物
Alzheimers Research & Therapy
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-09-12
DOI
10.1186/s13195-019-0532-x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Evidence-based Interpretation of Amyloid-β PET Results
- (2018) David Bergeron et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Upward drift in cerebrospinal fluid amyloid β 42 assay values for more than 10 years
- (2018) Suzanne E. Schindler et al. Alzheimers & Dementia
- Molecular imaging in dementia: Past, present, and future
- (2018) R. Laforce et al. Alzheimers & Dementia
- The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Amsterdam Dementia Cohort: Performing Research to Optimize Care
- (2018) Wiesje M. van der Flier et al. JOURNAL OF ALZHEIMERS DISEASE
- Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort
- (2018) Arno de Wilde et al. JAMA Neurology
- Concordance Between Cerebrospinal Fluid Biomarkers and [11C]PIB PET in a Memory Clinic Cohort
- (2018) Marissa Zwan et al. JOURNAL OF ALZHEIMERS DISEASE
- Assessing Amyloid Pathology in Cognitively Normal Subjects using [18F]Flutemetamol PET: Comparing Visual Reads and Quantitative Methods
- (2018) Lyduine Collij et al. JOURNAL OF NUCLEAR MEDICINE
- Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework
- (2017) Niklas Mattsson et al. NEUROBIOLOGY OF AGING
- Differential effects of cognitive reserve and brain reserve on cognition in Alzheimer disease
- (2017) Colin Groot et al. NEUROLOGY
- Correlation of florbetaben PET imaging and the amyloid peptide Aß42 in cerebrospinal fluid
- (2017) Carola G. Schipke et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Diagnostic impact of [18F]flutemetamol PET in early-onset dementia
- (2017) Marissa D. Zwan et al. Alzheimers Research & Therapy
- Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment
- (2017) Shorena Janelidze et al. JAMA Neurology
- Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies
- (2016) Lidia Sarro et al. BRAIN
- Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study
- (2016) Antoine Leuzy et al. BRAIN
- Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
- (2016) Sebastian Palmqvist et al. BRAIN
- Reference measurement procedure for CSF amyloid beta (Aβ)1-42and the CSF Aβ1-42/Aβ1-40ratio - a cross-validation study against amyloid PET
- (2016) Josef Pannee et al. JOURNAL OF NEUROCHEMISTRY
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
- (2015) Sylvia Villeneuve et al. BRAIN
- Diagnostic accuracy of 18F amyloid PET tracers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis
- (2015) Elizabeth Morris et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prevalence of Amyloid PET Positivity in Dementia Syndromes
- (2015) Rik Ossenkoppele et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Amyloid in dementia associated with familial FTLD: not an innocent bystander
- (2015) Georges Naasan et al. NEUROCASE
- Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
- (2015) Sebastian Palmqvist et al. NEUROLOGY
- The cerebrospinal fluid “Alzheimer profile”: Easily said, but what does it mean?
- (2014) Flora H. Duits et al. Alzheimers & Dementia
- Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease
- (2014) Niklas Mattsson et al. BRAIN
- Comparison of Simplified Parametric Methods for Visual Interpretation of 11C-Pittsburgh Compound-B PET Images
- (2014) M. D. Zwan et al. JOURNAL OF NUCLEAR MEDICINE
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions
- (2014) R. Ossenkoppele et al. NEUROLOGY
- Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease
- (2014) Niklas Mattsson et al. Annals of Clinical and Translational Neurology
- Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid
- (2013) Susan M. Landau et al. ANNALS OF NEUROLOGY
- Longitudinal Amyloid Imaging Using 11C-PiB: Methodologic Considerations
- (2013) B. N. M. van Berckel et al. JOURNAL OF NUCLEAR MEDICINE
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
- (2013) Victor L Villemagne et al. LANCET NEUROLOGY
- Impact of molecular imaging on the diagnostic process in a memory clinic
- (2012) Rik Ossenkoppele et al. Alzheimers & Dementia
- Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET
- (2012) Rik Ossenkoppele et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Cognitive reserve in ageing and Alzheimer's disease
- (2012) Yaakov Stern LANCET NEUROLOGY
- Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers
- (2012) M. Scholl et al. NEUROLOGY
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
- (2011) Victor L. Villemagne et al. ANNALS OF NEUROLOGY
- Absence of Pittsburgh Compound B Detection of Cerebral Amyloid β in a Patient With Clinical, Cognitive, and Cerebrospinal Fluid Markers of Alzheimer Disease
- (2009) Nigel J. Cairns et al. ARCHIVES OF NEUROLOGY
- Amyloid- (1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease
- (2009) C. Mulder et al. CLINICAL CHEMISTRY
- Cerebrospinal fluid tau and ptau181increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
- (2009) Anne M. Fagan et al. EMBO Molecular Medicine
- Relationships between biomarkers in aging and dementia
- (2009) W. J. Jagust et al. NEUROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started